-
PP2A, Autophagy, and C. albicans Biofilm Resistance
2026-09-11
The reference study identifies PP2A-dependent ATG protein phosphorylation as a regulatory link between autophagy, Candida albicans biofilm formation, and reduced antifungal efficacy. Its combination of PPH21 genetic disruption, rapamycin-induced autophagy, mechanistic protein analysis, and a mouse oral infection model provides a useful framework for antifungal drug resistance research.
-
AU-24118 and Resistance to PROTAC Degraders
2026-09-10
The reference study develops AU-24118, an orally bioavailable mSWI/SNF ATPase degrader that suppresses castration-resistant prostate cancer models and shows enhanced activity with enzalutamide. It also identifies SMARCA4 bromodomain mutations and ABCB1 overexpression as acquired resistance mechanisms, with ABCB1 inhibition restoring sensitivity across several PROTAC classes.
-
LPS–TLR4–YAP1 Maintains Hepatocyte Stemness
2026-09-10
Shao et al. identified portal-vein lipopolysaccharide as a niche-associated signal that helps maintain hepatocyte stemness through TLR4-dependent YAP1 activation. The study combines spatial, genetic, pharmacological, cellular, and surgical approaches, providing a mechanistic framework for studying hepatocyte dedifferentiation and liver repair.
-
PARP1/FAK/COL5A1 Signaling in Ovarian Cancer
2026-09-09
The reference study establishes a cholesterol-resistant ovarian cancer model and identifies PARP1/FAK/COL5A1 signaling as a mechanistic link between persistent cholesterol exposure, epithelial-mesenchymal transition, and tumor progression. Its findings position FAK-dependent signaling as a testable intervention point for cancer biology research while also highlighting the limits of translating an adaptive cell model into clinical disease.
-
Exosomal HMGB1 in Lupus Nephritis Endothelial Injury
2026-09-09
The reference study identifies podocyte-derived exosomes carrying HMGB1 as a mechanistic link between lupus nephritis and glomerular endothelial cell injury, with TRIM27 functioning as an important downstream mediator. Its combination of human samples, lupus-like disease models, exosome perturbation, cargo knockdown, and TRIM27 manipulation provides a framework for testing podocyte–endothelial communication.
-
Immunodominant B-Cell Epitopes for P. vivax
2026-09-08
This study integrates computational immunology, peptide serology, multiplex validation, and conservation analysis to identify species-specific Plasmodium vivax B-cell epitopes. Four candidates showed particularly strong diagnostic performance, while one MSP9 epitope helped distinguish asymptomatic infections, providing a potential foundation for precision malaria surveillance.
-
Deferasirox Fe3+ Chelate: Assay Design
2026-09-08
Deferasirox Fe3+ chelate offers a state-aware model for iron chelation research. This article explains how to distinguish ferric-loaded material from free deferasirox when designing beta-thalassemia, chronic anemia, and iron-overload assays.
-
Trilaurin: Practical Protocols and QC Guide
2026-09-07
Trilaurin (Glycerol Tridodecanoate, SKU BA7536) provides a water-insoluble C12 triacylglycerol for lipid particle formulation, organic-solvent preparation, and enzyme-catalyzed fatty-amine workflows. It should not be selected for water-only methods or prolonged storage as an aqueous solution without a validated formulation strategy.
-
Capillarisenol C Drives ER Stress-Linked Autophagy
2026-09-07
The reference study identifies capillarisenol C, a bisphenol isolated from Artemisia capillaris, as an inducer of ER stress-associated cytotoxic autophagy in HepG2 and Huh7 liver cancer cells. Its pharmacological and genetic experiments connect PERK–eIF2α and IRE1 activation with autophagy-dependent cell death, while 4-PBA rescue supports ER stress as a mechanistic requirement.
-
ATRA Reverses Cisplatin-Induced PARP Inhibitor Resistance
2026-09-05
The reference study shows that all-trans retinoic acid can reduce cisplatin-induced resistance to PARP inhibition in epithelial ovarian cancer models. Its sequential-treatment design links this effect to suppression of ALDH1A1, NAMPT, PARP1, and CHK1 expression together with reduced intracellular NAD+, supporting ATRA plus Niraparib as a mechanistically informed maintenance strategy.
-
ECL Western Blotting Substrate: Workflow Guide
2026-09-04
ECL Western Blotting Substrate (SKU K2187) provides a nonradioactive, luminol-based method for detecting HRP on immunoblots with chemiluminescent imaging. It is intended for HRP Western blot assays using X-ray film or CCD cameras, not for fluorescent or radioisotopic detection workflows.
-
Dabigatran Etexilate: Oral Thrombin Inhibition
2026-09-04
The reference review presents dabigatran etexilate as the first oral direct thrombin inhibitor marketed in the United States, emphasizing rapid, predictable anticoagulation without routine vitamin K antagonist monitoring. It connects the drug’s prodrug pharmacology and renal elimination with evidence in venous thromboembolism, nonvalvular atrial fibrillation, and acute VTE treatment, while highlighting bleeding risk and renal function as central limitations.
-
Machine Learning Designs LNPs for Microglia mRNA
2026-09-03
Rafiei, Shojaei, and Chau developed a machine learning workflow to connect lipid nanoparticle design with mRNA transfection and phenotype changes in activated microglia. The study identified HA-LNP2 as a lead formulation for IL10 mRNA and showed that its anti-inflammatory activity extended from a murine cell model to human iPSC-derived microglia.
-
Safe DNA Gel Stain for RNA Workflow Control
2026-09-03
Safe DNA Gel Stain supports safer DNA and RNA visualization when cloning, transcript quality control, or RNA-structure assays depend on recovering intact nucleic acids. Its blue-light compatibility helps reduce UV-associated damage, while defined in-gel and post-staining formats make it practical for routine molecular biology workflows.
-
Butylhydroxyanisole (BHA) in Cell Assays
2026-09-02
Learn how Butylhydroxyanisole (BHA), SKU C6525, can improve control of oxidation-related variability in cell viability, proliferation, and cytotoxicity workflows. This scenario-based guide covers solvent compatibility, stock preparation, controls, interpretation, and practical product-selection criteria.